Form 8-K - Current report:
SEC Accession No. 0001493152-21-028346
Filing Date
2021-11-15
Accepted
2021-11-15 08:46:41
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37962
2 ex99-1.htm EX-99.1 141660
3 logo_ex99-1.jpg GRAPHIC 35778
  Complete submission text file 0001493152-21-028346.txt   421458

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20211115.xsd EX-101.SCH 3020
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20211115_lab.xml EX-101.LAB 34238
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20211115_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 211406652
SIC: 2834 Pharmaceutical Preparations